Mean creatinine decrease after administration of intravenous contrast in patients with renal dysfunction: implications for assessment of post-contrast nephrotoxicity.

IF 1.1 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Acta radiologica Pub Date : 2025-07-01 Epub Date: 2025-03-20 DOI:10.1177/02841851251327895
Jeffrey H Newhouse, Firas Ahmed, James Ellis
{"title":"Mean creatinine decrease after administration of intravenous contrast in patients with renal dysfunction: implications for assessment of post-contrast nephrotoxicity.","authors":"Jeffrey H Newhouse, Firas Ahmed, James Ellis","doi":"10.1177/02841851251327895","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundContrast nephropathy risk is traditionally assessed by the proportion of patients whose post-contrast serum creatinine (SCr) increases exceed certain thresholds. However, this method can be misleading because of random threshold selections, overlooking post-contrast creatinine decreases, and discarding continuous renal function data. The main impact of contrast on renal function can be revealed by analyzing the mean changes in SCr and evaluating their significance.PurposeTo analyze published data permitting calculation of mean SCr changes after intravenous contrast.Material and MethodsWe identified publications including patients with pre-existing renal dysfunction who received modern contrast agents, specified contrast type and dose, and means and standard deviations of SCr measurements before and after contrast.ResultsIn 14 articles, including 2057 patients, mean SCr pre-contrast was 148.6 µmol/L (1.68 mg/dL); decreasing significantly to 144.1 µmol/L (1.63 mg/dL) after contrast. Significant diminutions occurred at post-contrast intervals of 4, 7, and 10 days, and in patients who received hydration therapy. Of the patients, 6.6% met the specific thresholds for contrast nephropathy as defined by individual studies.ConclusionThe slight significant improvement in SCr after iodinated contrast suggests that some prior estimates of the risk of contrast-induced acute kidney injury (AKI) have been erroneously high and corroborates the current view that the risk of clinically important AKI after contrast is unlikely in patients with moderate renal failure. Threshold-based investigations of nephropathy may be misleading. Mean post-contrast SCr decline should be considered for clinical decisions regarding contrast administration. Future studies on the renal effects of contrast should analyze means, variation, and significance of post-contrast SCr changes.</p>","PeriodicalId":7143,"journal":{"name":"Acta radiologica","volume":" ","pages":"775-781"},"PeriodicalIF":1.1000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta radiologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02841851251327895","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundContrast nephropathy risk is traditionally assessed by the proportion of patients whose post-contrast serum creatinine (SCr) increases exceed certain thresholds. However, this method can be misleading because of random threshold selections, overlooking post-contrast creatinine decreases, and discarding continuous renal function data. The main impact of contrast on renal function can be revealed by analyzing the mean changes in SCr and evaluating their significance.PurposeTo analyze published data permitting calculation of mean SCr changes after intravenous contrast.Material and MethodsWe identified publications including patients with pre-existing renal dysfunction who received modern contrast agents, specified contrast type and dose, and means and standard deviations of SCr measurements before and after contrast.ResultsIn 14 articles, including 2057 patients, mean SCr pre-contrast was 148.6 µmol/L (1.68 mg/dL); decreasing significantly to 144.1 µmol/L (1.63 mg/dL) after contrast. Significant diminutions occurred at post-contrast intervals of 4, 7, and 10 days, and in patients who received hydration therapy. Of the patients, 6.6% met the specific thresholds for contrast nephropathy as defined by individual studies.ConclusionThe slight significant improvement in SCr after iodinated contrast suggests that some prior estimates of the risk of contrast-induced acute kidney injury (AKI) have been erroneously high and corroborates the current view that the risk of clinically important AKI after contrast is unlikely in patients with moderate renal failure. Threshold-based investigations of nephropathy may be misleading. Mean post-contrast SCr decline should be considered for clinical decisions regarding contrast administration. Future studies on the renal effects of contrast should analyze means, variation, and significance of post-contrast SCr changes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾功能不全患者静脉注射造影剂后平均肌酐降低:对造影剂后肾毒性评估的意义。
造影剂肾病风险传统上是通过造影剂后血清肌酐(SCr)升高超过一定阈值的患者比例来评估的。然而,由于随机的阈值选择,忽略了对比后肌酐的下降,并且丢弃了连续的肾功能数据,这种方法可能会产生误导。对比剂对肾功能的主要影响可以通过分析SCr的平均变化并评价其意义来揭示。目的分析已发表的资料,计算静脉造影剂后SCr的平均变化。材料和方法我们检索了包括既往存在肾功能不全的患者的出版物,这些患者接受了现代造影剂,指定了造影剂类型和剂量,以及造影剂前后SCr测量的平均值和标准差。结果14篇文章2057例患者,对比前平均SCr为148.6µmol/L (1.68 mg/dL);对比后显著降低至144.1µmol/L (1.63 mg/dL)。在对比后间隔4、7和10天,以及接受水合治疗的患者中,出现了明显的减少。在患者中,6.6%的患者符合个别研究定义的造影剂肾病的特定阈值。结论碘造影剂后SCr的轻微显著改善表明,一些先前对造影剂诱导的急性肾损伤(AKI)风险的估计过高,并证实了目前的观点,即中度肾功能衰竭患者在造影剂后不太可能发生临床重要的AKI风险。基于阈值的肾病调查可能会产生误导。临床决定是否给药时应考虑造影剂后平均SCr下降。未来关于造影剂对肾脏影响的研究应分析造影剂后SCr变化的方法、变化和意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta radiologica
Acta radiologica 医学-核医学
CiteScore
2.70
自引率
0.00%
发文量
170
审稿时长
3-8 weeks
期刊介绍: Acta Radiologica publishes articles on all aspects of radiology, from clinical radiology to experimental work. It is known for articles based on experimental work and contrast media research, giving priority to scientific original papers. The distinguished international editorial board also invite review articles, short communications and technical and instrumental notes.
期刊最新文献
Percutaneous metallic stent placement for malignant extrahepatic biliary obstruction: single-center experience in 612 patients. Non-contrast coronary magnetic resonance angiography in myocardial bridge assessment: a CCTA-referenced diagnostic evaluation. Breast cancer and liver metastases: an imaging perspective on the potential of resectability. Prospective evaluation of time-resolved MRA in diagnosing and monitoring pulmonary arteriovenous malformations. Hip fracture detection on radiographs using an artificial intelligence-based support tool: a diagnostic accuracy study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1